Stock listing

A2JQTJ Stock Price, News, Filings & Events — Crinetics Pharmaceuticals, Inc.

Selected listing: A2JQTJ · LSX · EUR · DE

The selected listing A2JQTJ:LSX represents Crinetics Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative therapies for endocrine diseases and disorders. The company is actively advancing its pipeline of drug candidates and has recently made headlines with updates on clinical trials and regulatory filings. Investors can stay informed about upcoming events and market developments that may impact the company's growth and performance. Crinetics continues to position itself as a key player in the pharmaceutical industry with its commitment to addressing unmet medical needs.

A2JQTJ:LSXEURDEUpdated July 24, 2026
Crinetics Pharmaceuticals, Inc. logo
Ticker
A2JQTJ:LSX
Asset type
Stock
Market cap
$8.87B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Crinetics Pharmaceuticals, Inc. A2JQTJ:LSX stock context

The selected listing A2JQTJ:LSX represents Crinetics Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative therapies for endocrine diseases and disorders. The company is actively advancing its pipeline of drug candidates and has recently made headlines with updates on clinical trials and regulatory filings. Investors can stay informed about upcoming events and market developments that may impact the company's growth and performance. Crinetics continues to position itself as a key player in the pharmaceutical industry with its commitment to addressing unmet medical needs.

Research Crinetics Pharmaceuticals, Inc.

Alternate listings